These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15171356)

  • 41. Early and late sympathetic activation in hypertension.
    Mancia G; Di Rienzo M; Giannattasio C; Parati G; Grassi G
    Scand Cardiovasc J Suppl; 1998; 47():9-14. PubMed ID: 9540128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of changes in the sodium balance on plasma catecholamines and renin activity at rest and on their response to orthostatic stimulation in arterial hypertension].
    Morganti A; Pickering T; Lopez-Ovejero J; Laragh J
    Minerva Nefrol; 1981; 28(3):261-4. PubMed ID: 7036014
    [No Abstract]   [Full Text] [Related]  

  • 43. [Involvement of adiponectin in the pathogenesis of hypertension and hypertensive target-organ damage].
    Arita Y; Matsuzawa Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():222-7. PubMed ID: 15171373
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on the activity of the sympathetic nervous system in essential hypertension.
    Chobanian AV; Garvras H; Gavras I; Bresnahan M; Sullivan P; Melby JC
    J Human Stress; 1978 Sep; 4(3):22-8. PubMed ID: 690418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Insulin and arterial hypertension: role of hypersympathicotonia].
    Oganov RG; Aleksandrov A
    Ter Arkh; 2002; 74(12):5-7. PubMed ID: 12577828
    [No Abstract]   [Full Text] [Related]  

  • 46. Abnormalities in the regulation of sympathetic activity in human hypertension.
    de Champlain J; Cléroux J; Lebeau R; Gonzalez M; Nadeau R
    Clin Invest Med; 1987 Nov; 10(6):573-80. PubMed ID: 3326696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
    Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The contribution of the sympathetic nervous system to hypertension in diabetes mellitus.
    Kribben A; Philipp T
    Diabete Metab; 1989; 15(5 Pt 2):313-7. PubMed ID: 2693150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible role of the sympathetic nervous system in the pathogenesis of hypertension.
    Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(4):S57-9. PubMed ID: 3868712
    [No Abstract]   [Full Text] [Related]  

  • 50. Sympathetic factors in the cardiovascular complications of hypertension: evidence in genetic models for hypertension, stroke and atherosclerosis.
    Yamori Y; Nara Y; Mano M; Horie R
    J Hypertens Suppl; 1985 Dec; 3(4):S35-8. PubMed ID: 3868711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Suppression of the sympathetic component of the baroreceptor reflex in patients with arterial hypertension].
    Kuz'min AI; Medvedev OS; Anosova OB; Vikhert OA; Bykov AV
    Fiziol Cheloveka; 1989; 15(2):78-84. PubMed ID: 2759380
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin].
    Os I; Kjeldsen SE; Beckmann SL; Eide I; Hjermann I; Leren P; Westheim A
    Tidsskr Nor Laegeforen; 1987 Apr; 107(10-11):954-7. PubMed ID: 3299859
    [No Abstract]   [Full Text] [Related]  

  • 53. Increased regional sympathetic nervous activity in human hypertension: causes and consequences.
    Esler M; Lambert G; Jennings G
    J Hypertens Suppl; 1990 Dec; 8(7):S53-7. PubMed ID: 1965656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Some aspects of the physiopathology of arterial hypertension].
    Francischetti EA; Oigman W; Fagundes VG; Netto FR; Sanjuliani AF; Brandão AP
    Arq Bras Cardiol; 1984 Feb; 42(2):153-65. PubMed ID: 6089717
    [No Abstract]   [Full Text] [Related]  

  • 55. Catecholamines in essential hypertension.
    Lancet; 1977 May; 1(8021):1088-90. PubMed ID: 68186
    [No Abstract]   [Full Text] [Related]  

  • 56. Obesity-related hypertension and the insulin resistance syndrome.
    Landsberg L
    Trans Am Clin Climatol Assoc; 1995; 106():69-75; discussion 75-6. PubMed ID: 7483180
    [No Abstract]   [Full Text] [Related]  

  • 57. Obesity-Associated Organ Damage and Sympathetic Nervous Activity.
    Lambert EA; Esler MD; Schlaich MP; Dixon J; Eikelis N; Lambert GW
    Hypertension; 2019 Jun; 73(6):1150-1159. PubMed ID: 31067200
    [No Abstract]   [Full Text] [Related]  

  • 58. [Borderline hypertension and the role of the sympathetic nervous system].
    Kuramochi M; Hashiba K
    Nihon Rinsho; 1980 Sep; 38(9):3120-5. PubMed ID: 7253255
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique.
    Krantz DS; Manuck SB
    Psychol Bull; 1984 Nov; 96(3):435-64. PubMed ID: 6393178
    [No Abstract]   [Full Text] [Related]  

  • 60. Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Eur Heart J; 1982 Apr; 3(2):164-70. PubMed ID: 6211357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.